PuSH - Publikationsserver des Helmholtz Zentrums München

Export: TXT Text RIS Endnote (RIS) BIB BibTeX
Lichtmannegger, J. ; Leitzinger, C. ; Wimmer, R.* ; Schmitt, S. ; Schulz, S. ; Kabiri, Y. ; Eberhagen, C. ; Rieder, T.* ; Janik, D. ; Neff, F. ; Straub, B.K.* ; Schirmacher, P.* ; DiSpirito, A.A.* ; Bandow, N.* ; Baral, B.S.* ; Flatley, A. ; Kremmer, E. ; Denk, G.U.* ; Reiter, F.P.* ; Hohenester, S.* ; Eckardt-Schupp, F. ; Dencher, N.A.* ; Adamski, J. ; Sauer, V.* ; Niemietz, C.* ; Schmidt, H.H.* ; Merle, U.* ; Gotthardt, D.N.* ; Kroemer, G.* ; Weiss, K.H.* ; Zischka, H.

Methanobactin reverses acute liver failure in a rat model of Wilson disease.

J. Clin. Invest. 126, 2721-2735 (2016)
Verlagsversion DOI PMC
Open Access Gold
In Wilson disease (WD), functional loss of ATPase copper-transporting β (ATP7B) impairs biliary copper excretion, leading to excessive copper accumulation in the liver and fulminant hepatitis. Current US Food and Drug Administration- and European Medicines Agency-approved pharmacological treatments usually fail to restore copper homeostasis in patients with WD who have progressed to acute liver failure, leaving liver transplantation as the only viable treatment option. Here, we investigated the therapeutic utility of methanobactin (MB), a peptide produced by Methylosinus trichosporium OB3b, which has an exceptionally high affinity for copper. We demonstrated that ATP7B-deficient rats recapitulate WD-associated phenotypes, including hepatic copper accumulation, liver damage, and mitochondrial impairment. Short-term treatment of these rats with MB efficiently reversed mitochondrial impairment and liver damage in the acute stages of liver copper accumulation compared with that seen in untreated ATP7B-deficient rats. This beneficial effect was associated with depletion of copper from hepatocyte mitochondria. Moreover, MB treatment prevented hepatocyte death, subsequent liver failure, and death in the rodent model. These results suggest that MB has potential as a therapeutic agent for the treatment of acute WD.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
12.575
2.829
81
88
Tags
Anmerkungen
Besondere Publikation
Auf Hompepage verbergern

Zusatzinfos bearbeiten
Eigene Tags bearbeiten
Privat
Eigene Anmerkung bearbeiten
Privat
Auf Publikationslisten für
Homepage nicht anzeigen
Als besondere Publikation
markieren
Publikationstyp Artikel: Journalartikel
Dokumenttyp Wissenschaftlicher Artikel
Schlagwörter Methylosinus-trichosporium Ob3b; Methane-oxidizing Bacteria; D-penicillamine Prevents; Permeability Transition; Copper-acquisition; Cinnamon Rats; Gene-therapy; Mitochondrial; Transplantation; Cells
Sprache englisch
Veröffentlichungsjahr 2016
HGF-Berichtsjahr 2016
ISSN (print) / ISBN 0021-9738
e-ISSN 1558-8238
Zeitschrift Journal of Clinical Investigation
Quellenangaben Band: 126, Heft: 7, Seiten: 2721-2735 Artikelnummer: , Supplement: ,
Verlag American Society of Clinical Investigation
Verlagsort Ann Arbor
Begutachtungsstatus Peer reviewed
Institut(e) Institute of Molecular Toxicology and Pharmacology (TOX)
Molekulare Endokrinologie und Metabolismus (MEM)
Institute of Pathology (PATH)
Institute of Molecular Immunology (IMI)
Institute of Radiation Biology (ISB)
POF Topic(s) 30203 - Molecular Targets and Therapies
30201 - Metabolic Health
30504 - Mechanisms of Genetic and Environmental Influences on Health and Disease
30202 - Environmental Health
Forschungsfeld(er) Enabling and Novel Technologies
Genetics and Epidemiology
Immune Response and Infection
Radiation Sciences
PSP-Element(e) G-505200-003
G-505200-001
G-505600-001
G-500300-001
G-501793-001
G-500200-001
DOI 10.1172/JCI85226
WOS ID WOS:000379094800032
Scopus ID 84978412130
PubMed ID 27322060
Erfassungsdatum 2016-07-04
[➜Korrektur melden]